Views

CrossRef citations to date

Altmetric

Original Article: Clinical

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

Francesco ZajaClinica Ematologica ed Unità di Terapie Cellulari ‘Carlo Melzi’, DAME, University of Udine, Udine, Italy; Correspondence[email protected]

Flavia SalviS.C. Ematologia, A.O. SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy;

Maura RossiUnit of Haemolymphopathology, Department of Experimental, Diagnostic and Specialty Medicine, University Hospital of Bologna, Bologna, Italy;

Elena SabattiniUnit of Haemolymphopathology, Department of Hematology and Oncology, University Hospital of Bologna, Bologna, Italy;

Andrea EvangelistaUnit of Haemolymphopathology, Department of Hematology and Oncology, University Hospital of Bologna, Bologna, Italy;

Giovannino CicconeUnit of Clinical Epidemiology, AOU Città della Salute e della Scienza di Torino and CPO Piemonte, Torino, Italy;

Emanuele AngelucciU.O.C. Ematologia, IRCCS A.O.U. San Martino-IST, Genova, Italy;

http://orcid.org/0000-0002-6512-6080

Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;

Manuela ZanniDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;

Marco LadettoS.C. Ematologia, A.O. SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy;

Annalisa ChiappellaS.C. Ematologia, A.O.U. Città della Salute e della Scienza, Torino, Italy;

Umberto VitoloS.C. Ematologia, A.O.U. Città della Salute e della Scienza, Torino, Italy;

Pier Luigi ZinzaniInstitute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy;

Catello CalifanoU.O. Medicina-Oncoematologia, Ospedale Umberto I, Nocera Inferiore, Italy;

Alessandra TucciS.C. Ematologia e Dipartimento Oncologia Medica Spedali Civili, Brescia, Italy;

Caterina PattiU.O.C. di Ematologia, Ospedale V. Cervello, Palermo, Italy;

Stefano A. PileriHaematopathology Unit, European Institute of Oncology, Milano/University School of Medicine, Bologna, Italy;

Valentina LentiFondazione Italiana Linfomi, Alessandria, Italy;

Pier Paolo PiccalugaUnit of Haemolymphopathology, Department of Experimental, Diagnostic and Specialty Medicine, University Hospital of Bologna, Bologna, Italy;

Federica CavalloUniversity of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy;

Stefano VolpettiClinica Ematologica ed Unità di Terapie Cellulari ‘Carlo Melzi’, Azienda Sanitaria Universitaria Integrata, Udine, Italy;

Giulia PeraliClinica Ematologica ed Unità di Terapie Cellulari ‘Carlo Melzi’, Azienda Sanitaria Universitaria Integrata, Udine, Italy;

Sarit AssoulineDivision of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada;

Koren Kathleen MannLady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada;

Ryan MorinDepartment of Molecular Biology and Biochemistry, School of Computing Science, Simon Fraser University, Vancouver, BC, Canada

Miguel AlcaideDepartment of Molecular Biology and Biochemistry, School of Computing Science, Simon Fraser University, Vancouver, BC, Canada

Kevin BushellDepartment of Molecular Biology and Biochemistry, School of Computing Science, Simon Fraser University, Vancouver, BC, Canada

Renato FaninClinica Ematologica ed Unità di Terapie Cellulari ‘Carlo Melzi’, DAME, University of Udine, Udine, Italy;

Alessandro LevisFondazione Italiana Linfomi, Alessandria, Italy;

show all

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

ICMJE Form for Disclosure of Potential Conflicts of Interest

Supplemental data

Supplemental file 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

ICMJE Form for Disclosure of Potential Conflicts of Interest

Supplemental data

Supplemental file 1

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date